Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 92,250 shares at $2.62 ($242K) on 2011-11-11, disclosed to the SEC on 2011-11-14.
Scheduled sale ($242k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVNR | SELL | 2014-10-24 | $25K | — | Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |